Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
14.69
-13.12 (-47.18%)
At close: Feb 11, 2026, 4:00 PM EST
14.98
+0.29 (1.97%)
After-hours: Feb 11, 2026, 7:59 PM EST
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $793.83 million as of February 11, 2026. Its market cap has increased by 49.31% in one year.
Market Cap
793.83M
Enterprise Value
422.82M
1-Year Change
49.31%
Ranking
Category
Stock Price
$14.69
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has increased from $393.35M to $793.83M, an increase of 101.81%. That is a compound annual growth rate of 69.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.50B | 2.43% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 1.59B |
| Agios Pharmaceuticals | 1.58B |
| Relay Therapeutics | 1.56B |
| Monte Rosa Therapeutics | 1.55B |
| uniQure | 1.54B |
| Veradermics | 1.51B |
| Kodiak Sciences | 1.45B |
| Trevi Therapeutics | 1.44B |